Scinai Immunotherapeutics Plunges 10.04% Amid Reverse Split

Scinai's stock price plummeted by 10.04% during pre-market trading on July 2, 2025, marking a significant downturn for the company.

Scinai Immunotherapeutics recently announced a 1-for-10 reverse stock split, which means shareholders will now hold one share for every ten shares they previously owned. This corporate action is aimed at increasing the stock price and potentially attracting more investors.

Additionally, Scinai Immunotherapeutics has been making strides in restructuring its debt and focusing on growth opportunities. The company has also been working to regain compliance with Nasdaq listing requirements, which could further stabilize its stock performance.